NMC nod to 150 MBBS seats at GMC Eluru

Visakhapatnam: Bringing good news to the medical aspirants in Andhra Pradesh, the Medical Assessment and Rating Board of National Medical Commission (NMC) has given its nod for 150 MBBS seats at Government Medical College in Eluru.

The apex medical education regulatory body NMC has permitted the State to commence the MBBS admission in 150 seats at the medical college from the academic year 2023-2024.

This comes after an inspection was conducted by a team from NMC who visited the college and took stock of the infrastructural facilities, including the faculty, needed to start the college on Wednesday.

Also read- Five Medical Colleges In Andhra Pradesh Await NMC Approval

Following this, a report was submitted by the Medical Assessment and Rating Board and the approval was granted by NMC, reports TOI 

NMC has sought submission of essential undertakings and documents from authorities, so that it could issue the Letter of Permission for starting the medical college from academic year 2023–24.

Currently, three medical colleges in Eluru, Vizianagaram and Nandyal have been granted permission to commence its classes from this year.

Medical Dialogues team had earlier reported that medical colleges at Eluru, Vizianagaram, Rajamahendravaram, Nandyal and Machilipatnam districts of the State will commence the MBBS admission process in 150 MBBS seats each.

It was expected that the NMC would soon give its permission after Dr. NTR University of Health Sciences gave its permission to commence academic classes in the five medical colleges.

The AP Cabinet had earlier given approval for 3,530 posts for five new medical colleges in Nandyal, Machilipatnam, Eluru, Rajamahendravaram and Vizianagaram which are all set to start from next academic year (2023-24).

As per NMC norms, 222 posts are allotted to each medical college and 484 posts to the affiliated teaching hospital. Accordingly, the Cabinet has decided on 3,530 posts at the rate of 706 posts for each medical college.

Also read- NMC Nod For 150 MBBS Seats In Vizianagaram Govt Medical College



from Medical News, Health News Latest, Medical News Today - Medical Dialogues | https://ift.tt/7p5uMnY

Comments

Post a Comment

Popular posts from this blog

'Details sought include Third-party info, hence exempted under RTI Act': NMC on RTI query on Faculty Gap in Medical Colleges

Image
New Delhi:  Stating that the details sought under the RTI includes third-party information, the National Medical Commission (NMC) has refused to disclose the names of the medical colleges that fell short on faculty counts and other teaching infrastructure. Recently activist Dr. KV Babu filed an application under the Right to Information Act seeking the details of the notices issued by the NMC Undergraduate Medical Education Board (UGMEB) to the medical colleges for deficiencies in Clinical Material and staff during the period from 01/01/2023 to 30/04/2024. He also sought to know the details of the fine imposed or the action taken by the NMC UG Board from 01/01/2023 to 30/04/2024. In response, the Apex medical regulatory body in India has said that the concerned information includes third party information. "Since the information sought by you, includes third party information, hence the same is exempted for as per Section 8(1) (j) of the Right to Information Act, 2005," th...
Read more

Zasocitinib therapy highly efficacious for treatment of severe plaque psoriasis: JAMA

Image
A recent study published in the Journal of American Medical Association revealed that Zasocitinib could be a breakthrough in the treatment of moderate to severe plaque psoriasis. Psoriasis is a chronic inflammatory skin condition characterized by red, scaly patches, affects millions throughout the globe. While several treatments exist, the demand for new, effective, and well-tolerated oral therapies remains high. Zasocitinib, a highly selective allosteric tyrosine kinase 2 (TYK2) inhibitor, emerges as a promising candidate to meet this need. This trial was conducted between August 2021 and September 2022 across 55 centers in the US and Canada and found that Zasocitinib not only significantly improved skin clearance in patients but also expressed a favorable safety and tolerability profile. The study enrolled a total of 287 participants aged between 18 and 70 years, each with a Psoriasis Area and Severity Index (PASI) score of 12 or greater, a Physician’s Global Assessment score of 3...
Read more

New wearable laser device may monitor brain blood flow to gauge stroke risk, reports research

Image
Researchers have developed a laser-based device that can be placed on the head to non-invasively monitor changes in brain blood flow and volume. The new device could one day help save lives by offering a direct and simple way to assess stroke risk based on physiological markers rather than indirect markers like lifestyle factors. Strokes occur when blood flow to the brain is blocked or reduced, causing debilitating brain cell damage. With about 15 million people worldwide affected by strokes each year, it is the second leading cause of death and a leading cause of long-term disability. “The lack of a cost-effective and scalable stroke risk assessment system complicates long-term stroke prevention because a physician can’t tell whether a patient’s risk is stable or worsening,” said research team member Simon Mahler, a postdoctoral scholar in Changhuei Yang’s laboratory at the California Institute of Technology. “This new method could help catch early signs of increased stroke risk, w...
Read more